(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide

C132H113N19O8S4 — CID 159268560

IUPAC(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide
SMILESO=C(/C=C/C1CC1)Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1.O=C(CCCCCCCO)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.O=C(CCc1cccs1)Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)C1CC1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)c1cccs1.O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1
InChIInChI=1S/C25H27N3O2.C22H17N3OS2.C22H15N3OS.C21H20N4O2.C21H17N3OS.C21H17N3O/c29-15-7-3-1-2-4-10-24(30)26-21-13-14-23-22(17-21)25(28-27-23)20-12-11-18-8-5-6-9-19(18)16-20;26-21(10-8-16-5-3-11-27-16)23-15-7-9-18-17(13-15)22(25-24-18)20-12-14-4-1-2-6-19(14)28-20;26-22(20-6-3-11-27-20)23-17-9-10-19-18(13-17)21(25-24-19)16-8-7-14-4-1-2-5-15(14)12-16;26-20(12-4-5-12)22-15-3-1-2-14(10-15)19-17-11-16(8-9-18(17)24-25-19)23-21(27)13-6-7-13;25-20(10-7-13-5-6-13)22-15-8-9-17-16(12-15)21(24-23-17)19-11-14-3-1-2-4-18(14)26-19;25-21(14-6-7-14)22-17-9-10-19-18(12-17)20(24-23-19)16-8-5-13-3-1-2-4-15(13)11-16/h5-6,8-9,11-14,16-17,29H,1-4,7,10,15H2,(H,26,30)(H,27,28);1-7,9,11-13H,8,10H2,(H,23,26)(H,24,25);1-13H,(H,23,26)(H,24,25);1-3,8-13H,4-7H2,(H,22,26)(H,23,27)(H,24,25);1-4,7-13H,5-6H2,(H,22,25)(H,23,24);1-5,8-12,14H,6-7H2,(H,22,25)(H,23,24)/b;;;;10-7+;
InChIKeyKXKIMXAFUNMYPA-FWCIJNJJSA-N
MW2221.75 g/mol
LogP31.44
Rot. Bonds29

About (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide

(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide (PubChem CID 159268560) has the molecular formula C132H113N19O8S4 and a molecular weight of 2221.75 g/mol. Its IUPAC name is (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide.

Molecular Properties

Compound Name(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide
PubChem CID159268560
Molecular FormulaC132H113N19O8S4
Molecular Weight2221.75 g/mol
Exact Mass2219.79
IUPAC Name(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide
SMILESO=C(/C=C/C1CC1)Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1.O=C(CCCCCCCO)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.O=C(CCc1cccs1)Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)C1CC1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)c1cccs1.O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1
InChIInChI=1S/C25H27N3O2.C22H17N3OS2.C22H15N3OS.C21H20N4O2.C21H17N3OS.C21H17N3O/c29-15-7-3-1-2-4-10-24(30)26-21-13-14-23-22(17-21)25(28-27-23)20-12-11-18-8-5-6-9-19(18)16-20;26-21(10-8-16-5-3-11-27-16)23-15-7-9-18-17(13-15)22(25-24-18)20-12-14-4-1-2-6-19(14)28-20;26-22(20-6-3-11-27-20)23-17-9-10-19-18(13-17)21(25-24-19)16-8-7-14-4-1-2-5-15(14)12-16;26-20(12-4-5-12)22-15-3-1-2-14(10-15)19-17-11-16(8-9-18(17)24-25-19)23-21(27)13-6-7-13;25-20(10-7-13-5-6-13)22-15-8-9-17-16(12-15)21(24-23-17)19-11-14-3-1-2-4-18(14)26-19;25-21(14-6-7-14)22-17-9-10-19-18(12-17)20(24-23-19)16-8-5-13-3-1-2-4-15(13)11-16/h5-6,8-9,11-14,16-17,29H,1-4,7,10,15H2,(H,26,30)(H,27,28);1-7,9,11-13H,8,10H2,(H,23,26)(H,24,25);1-13H,(H,23,26)(H,24,25);1-3,8-13H,4-7H2,(H,22,26)(H,23,27)(H,24,25);1-4,7-13H,5-6H2,(H,22,25)(H,23,24);1-5,8-12,14H,6-7H2,(H,22,25)(H,23,24)/b;;;;10-7+;
InChIKeyKXKIMXAFUNMYPA-FWCIJNJJSA-N
XLogP31.44
TPSA396.01 Ų
H-Bond Donors14
H-Bond Acceptors18
Rotatable Bonds29
Heavy Atoms163
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002221.75
LogP ≤ 531.44
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;pentakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[5-[(2-thiophen-2-ylacetyl)amino]-1H-indazol-3-yl]benzamide;4-(3H-isoindol-1-yl)-N-(4-oxopentyl)benzamide;methane
CID 158058235
(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide
CID 158188335
N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;pentakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[5-[(2-thiophen-2-ylacetyl)amino]-1H-indazol-3-yl]benzamide;ethane;4-(3H-isoindol-1-yl)-N-(4-oxopentyl)benzamide
CID 158332021
N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]acetamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-3-hydroxy-2,2-dimethylpropanamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-3-hydroxy-2-phenylpropanamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide
CID 158777055
N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;pentakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[5-[(2-thiophen-2-ylacetyl)amino]-1H-indazol-3-yl]benzamide;4-(3H-isoindol-1-yl)-N-(4-oxopentyl)benzamide
CID 160867746
N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;pentakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[5-[(2-thiophen-2-ylacetyl)amino]-1H-indazol-3-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide;methane
CID 161676326
N-(2-acetamidoethyl)-3-(1-benzothiophen-2-yl)-4-fluoro-1H-indazole-5-carboxamide;N-[(2S)-1-amino-1-oxopropan-2-yl]-3-(1-benzothiophen-2-yl)-4-fluoro-1H-indazole-5-carboxamide;3-(1-benzothiophen-2-yl)-4-fluoro-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]-1H-indazole-5-carboxamide;3-(1-benzothiophen-2-yl)-4-fluoro-N-(2-thiophen-2-ylethyl)-1H-indazole-5-carboxamide;N-cyclopropyl-4-fluoro-3-naphthalen-2-yl-1H-indazole-5-carboxamide
CID 161803344

Frequently Asked Questions

What is the IUPAC name of (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide?
The IUPAC name of (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide (CID 159268560) is (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide.
What is the SMILES notation for (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide?
The canonical SMILES for (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide is O=C(/C=C/C1CC1)Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1.O=C(CCCCCCCO)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.O=C(CCc1cccs1)Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)C1CC1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)c1cccs1.O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1.
What is the InChIKey of (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide?
The InChIKey is KXKIMXAFUNMYPA-FWCIJNJJSA-N. The full InChI is InChI=1S/C25H27N3O2.C22H17N3OS2.C22H15N3OS.C21H20N4O2.C21H17N3OS.C21H17N3O/c29-15-7-3-1-2-4-10-24(30)26-21-13-14-23-22(17-21)25(28-27-23)20-12-11-18-8-5-6-9-19(18)16-20;26-21(10-8-16-5-3-11-27-16)23-15-7-9-18-17(13-15)22(25-24-18)20-12-14-4-1-2-6-19(14)28-20;26-22(20-6-3-11-27-20)23-17-9-10-19-18(13-17)21(25-24-19)16-8-7-14-4-1-2-5-15(14)12-16;26-20(12-4-5-12)22-15-3-1-2-14(10-15)19-17-11-16(8-9-18(17)24-25-19)23-21(27)13-6-7-13;25-20(10-7-13-5-6-13)22-15-8-9-17-16(12-15)21(24-23-17)19-11-14-3-1-2-4-18(14)26-19;25-21(14-6-7-14)22-17-9-10-19-18(12-17)20(24-23-19)16-8-5-13-3-1-2-4-15(13)11-16/h5-6,8-9,11-14,16-17,29H,1-4,7,10,15H2,(H,26,30)(H,27,28);1-7,9,11-13H,8,10H2,(H,23,26)(H,24,25);1-13H,(H,23,26)(H,24,25);1-3,8-13H,4-7H2,(H,22,26)(H,23,27)(H,24,25);1-4,7-13H,5-6H2,(H,22,25)(H,23,24);1-5,8-12,14H,6-7H2,(H,22,25)(H,23,24)/b;;;;10-7+;.
What are the key properties of (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide?
(E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide has a molecular weight of 2221.75 g/mol, XLogP of 31.44, 29 rotatable bonds, 14 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-cyclopropylprop-2-enamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-thiophen-2-ylpropanamide;N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide is sourced from PubChem (CID 159268560), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).